Yifan Zhai Selected Research

Heme Oxygenase-1

10/2021

High dose expression of heme oxigenase-1 induces retinal degeneration through ER stress-related DDIT3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yifan Zhai Research Topics

Disease

14	Neoplasms (Cancer) 11/2023 - 04/2003
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 01/2019
4	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 01/2022
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2022
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2022
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 12/2022
2	Stomach Neoplasms (Stomach Cancer) 11/2023 - 05/2018
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 12/2022
2	Retinal Degeneration 01/2022 - 10/2021
1	Parkinson Disease (Parkinson's Disease) 01/2024
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2024
1	Body Weight (Weight, Body) 12/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2023
1	Hypoxia (Hypoxemia) 09/2023
1	Pathologic Processes 01/2023
1	Astrocytoma (Pilocytic Astrocytoma) 01/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023
1	Tumor Lysis Syndrome 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Multiple Myeloma 12/2022
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 12/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Leukemia 01/2022
1	Blindness (Hysterical Blindness) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2021
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2019
1	Adenocarcinoma 05/2018
1	Breast Neoplasms (Breast Cancer) 04/2003

Drug/Important Bio-Agent (IBA)

7	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2022
6	olverembatinibIBA 01/2023 - 01/2019
5	LisaftoclaxIBA 01/2023 - 01/2022
3	osimertinibIBA 11/2022 - 01/2022
2	CaspasesIBA 11/2023 - 12/2022
2	pelcitoclaxIBA 11/2023 - 11/2022
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2022
2	EnzymesIBA 01/2022 - 10/2021
1	RNA (Ribonucleic Acid)IBA 01/2024
1	Small Nuclear RNA (snRNA)IBA 01/2024
1	RotenoneIBA 01/2024
1	Glycerol (Glycerine)FDA LinkGeneric 12/2023
1	GlycogenIBA 12/2023
1	ChitinIBA 09/2023
1	Protons (Proton)IBA 09/2023
1	Adenosine Triphosphate (ATP)IBA 09/2023
1	venetoclaxIBA 01/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	Mitogen-Activated Protein KinasesIBA 01/2023
1	SenotherapeuticsIBA 01/2023
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2023
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2023
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2023
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2022
1	ErbB Receptors (EGF Receptor)IBA 07/2022
1	trametinibIBA 07/2022
1	Aldehyde DehydrogenaseIBA 07/2022
1	Drug CombinationsIBA 07/2022
1	MitogensIBA 07/2022
1	Tetrazolium SaltsIBA 07/2022
1	Carboplatin (JM8)FDA LinkGeneric 07/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	bcr-abl Fusion ProteinsIBA 01/2022
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Cytochrome P-450 CYP2C9IBA 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 01/2022
1	Cytochrome P-450 CYP2C19IBA 01/2022
1	STAT5 Transcription FactorIBA 01/2022
1	Cytochrome P-450 CYP3AIBA 01/2022
1	HomoharringtonineIBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Heme Oxygenase-1IBA 10/2021
1	Heme (Haem)IBA 10/2021
1	pembrolizumabIBA 11/2019
1	Immune Checkpoint InhibitorsIBA 11/2019
1	Imatinib Mesylate (Gleevec)FDA Link 01/2019
1	ponatinibIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Sincalide FDA Link 05/2018
1	Glycoproteins (Glycoprotein)IBA 04/2003
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2003
1	LigandsIBA 04/2003

Therapy/Procedure

6	Therapeutics 01/2023 - 05/2018
1	Drug Therapy (Chemotherapy) 05/2018